Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

NuPathe Inc PATH

Sector: Healthcare | Sub-Sector: Biotechnology

Price: N/A | Change: N/A | % Change: N/A
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 4.49/1.57
top

Snapshot

Last Traded: N/A Transaction Volume: 0
Open: N/A Previous Close: N/A
Bid: N/A Ask: N/A
Bid Size: 0 Ask Size: 0
Market Cap: N/A Shares Out: 33.5m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • Intellectual Property

    0 stars

    NuPathe exclusively owns all worldwide rights to the migraine patch, with IP protection in the U.S. through 2027. http://www.stockhouse...

    4.5 stars


  • NASDAQ Target for PATH

    0 stars

    The NASDAQ target for PATH is $6.00 but with a yes vote from the FDA on January 17, this will need to be revised much higher. http://www...

    4.5 stars


  • She's on the Move !

    0 stars

    At this rate, today will be last chance to get in under $3.00. A superstar biotech in the make here.

    4.5 stars


  • No Competitors

    0 stars

    Very important to realize here that Nupathe will be the only patch delivery system of migrane medication on the market. The number of...

    4.5 stars


  • RE: $PATH Gaining Momentum

    0 stars

    Cool. What is their price target? Personally I think this stock with break $10 on an FDA yes vote in January. I base this on the very low...

    4.5 stars